Colabora Bipodex Colabora

NEUROIMAGING AND CSF BIOMARKER PROGRAM

ALZHEIMER’S DRUG DISCOVERY FOUNDATION (ADDF)

Objeto

Topic: Alzheimer.

Destination: Development and validation of biomarkers for which there is a clear clinical need in Alzheimer’s disease and related dementias.

Budget: $600.000.

Duration: 1 year.

Estás interesado?

Llena el siguiente formulario para recibir más información: